Assignee
SUPERGEN INC
US·46 granted patents·18 pending applications·1,420 citations·filing 1994–2011
Top patents by PatentIndex Score
64 records- 0198US7700567B2Oligonucleotide analogues incorporating 5-aza-cytosine thereinSUPERGEN INC·Filed 2005·Granted Apr 20, 2010·26 cites·20 claims
- 0297US7250416B2Azacytosine analogs and derivativesSUPERGEN INC·Filed 2005·Granted Jul 31, 2007·25 cites·43 claims
- 0396US7750007B2Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitorsSUPERGEN INC·Filed 2007·Granted Jul 6, 2010·97 cites·9 claims
- 0496US6998391B2Method for treating diseases associated with abnormal kinase activitySUPERGEN INC·Filed 2002·Granted Feb 14, 2006·115 cites·20 claims
- 0596US6905669B2Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylaseSUPERGEN INC·Filed 2001·Granted Jun 14, 2005·138 cites·18 claims
- 0694US7998966B2Axl kinase inhibitorsSUPERGEN INC·Filed 2008·Granted Aug 16, 2011·30 cites·8 claims
- 0794US6319943B1Oral formulation for paclitaxelSUPERGEN INC·Filed 2000·Granted Nov 20, 2001·63 cites·23 claims
- 0893US6613753B2Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2001·Granted Sep 2, 2003·43 cites·13 claims
- 0993US6509370B1Paclitaxel formulationSUPERGEN INC·Filed 2002·Granted Jan 21, 2003·36 cites·26 claims
- 1093US6136846AFormulation for paclitaxelSUPERGEN INC·Filed 1999·Granted Oct 24, 2000·113 cites·38 claims
- 1192US7939546B2Quinoline derivatives for modulating DNA methylationSUPERGEN INC·Filed 2009·Granted May 10, 2011·14 cites·17 claims
- 1292US7276228B2Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylaseSUPERGEN INC·Filed 2005·Granted Oct 2, 2007·10 cites·16 claims
- 1391US6482830B1Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted Nov 19, 2002·27 cites·22 claims
- 1490US5602112APharmaceutical formulationSUPERGEN INC·Filed 1994·Granted Feb 11, 1997·70 cites·31 claims
- 1589US7135464B2Method of administering decitabineSUPERGEN INC·Filed 2004·Granted Nov 14, 2006·33 cites·11 claims
- 1689US6420378B1Inhibition of abnormal cell proliferation with camptothecin and combinations including the sameSUPERGEN INC·Filed 2000·Granted Jul 16, 2002·21 cites·3 claims
- 1789US6284747B1Pharmaceutical formulationSUPERGEN INC·Filed 2000·Granted Sep 4, 2001·16 cites·16 claims
- 1888US6828346B2Methods for administration of paclitaxelSUPERGEN INC·Filed 2003·Granted Dec 7, 2004·26 cites·48 claims
- 1986US6710195B2Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2002·Granted Mar 23, 2004·21 cites·70 claims
- 2086US6583125B2Formulation of nitrogen mustardSUPERGEN INC·Filed 2001·Granted Jun 24, 2003·11 cites·14 claims
- 2185US7790746B2Quinoline derivatives for modulating DNA methylationSUPERGEN INC·Filed 2007·Granted Sep 7, 2010·10 cites·16 claims
- 2285US7060290B1Phosphocholine linked prodrug derivativesSUPERGEN INC·Filed 2000·Granted Jun 13, 2006·34 cites·12 claims
- 2385US6982253B2Liquid formulation of decitabine and use of the sameSUPERGEN INC·Filed 2002·Granted Jan 3, 2006·21 cites·79 claims
- 2484US6664233B1Combination therapy including 9-nitro-20(S)-camptothecin and bleomycinSUPERGEN INC·Filed 2000·Granted Dec 16, 2003·11 cites·4 claims
- 2581US6174873B1Oral administration of adenosine analogsSUPERGEN INC·Filed 1998·Granted Jan 16, 2001·63 cites·11 claims
- 2679US6509027B2Injectable pharmaceutical composition comprising coated particles of camptothecinSUPERGEN INC·Filed 2001·Granted Jan 21, 2003·11 cites·38 claims
- 2779US6497896B2Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecinSUPERGEN INC·Filed 2001·Granted Dec 24, 2002·10 cites·39 claims
- 2878US7144873B2Kit for delivering decitabine in vivoSUPERGEN INC·Filed 2004·Granted Dec 5, 2006·9 cites·14 claims
- 2978US6017948AWater-miscible pharmaceutical compositionsSUPERGEN INC·Filed 1998·Granted Jan 25, 2000·45 cites·25 claims
- 3078US5824668AFormulation for administration of steroid compoundsSUPERGEN INC·Filed 1996·Granted Oct 20, 1998·56 cites·43 claims
- 3178US5804568APharmaceutical formulationSUPERGEN INC·Filed 1997·Granted Sep 8, 1998·32 cites·17 claims
- 3276US7037900B2Composition and method for treating graft-versus-host diseaseSUPERGEN INC·Filed 2001·Granted May 2, 2006·7 cites·39 claims
- 3375US6191119B1Combination therapy including 9-nitro-20(S)-camptothecinSUPERGEN INC·Filed 1999·Granted Feb 20, 2001·29 cites·4 claims
- 3474US7071202B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted Jul 4, 2006·4 cites·11 claims
- 3570US6756381B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereofSUPERGEN INC·Filed 2002·Granted Jun 29, 2004·2 cites·19 claims
- 3670US6485514B1Local delivery of therapeutic agentsSUPERGEN INC·Filed 1997·Granted Nov 26, 2002·42 cites·5 claims
- 3770US6218374B1Pharmaceutical formulationSUPERGEN INC·Filed 1999·Granted Apr 17, 2001·20 cites·10 claims
- 3870US6048845APharmaceutical formulationSUPERGEN INC·Filed 1998·Granted Apr 11, 2000·20 cites·28 claims
- 3966US7820684B2Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using sameSUPERGEN INC·Filed 2008·Granted Oct 26, 2010·0 cites·13 claims
- 4063US6977247B2Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analogSUPERGEN INC·Filed 2002·Granted Dec 20, 2005·1 cites·10 claims
- 4163US2005043225A1Pharmaceutical formulationSUPERGEN INC·Filed 2004·Application pending·0 cites
- 4262US6489369B1Phosphocholine surfactants and their useSUPERGEN INC·Filed 2000·Granted Dec 3, 2002·1 cites·13 claims
- 4362US2004109846A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 4461US2010062992A1Salts of 5-AzacytidineSUPERGEN INC·Filed 2009·Application pending·0 cites
- 4561US2004052864A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 4659US6281223B1Radioenhanced camptothecin derivative cancer treatmentsSUPERGEN INC·Filed 1999·Granted Aug 28, 2001·23 cites·15 claims
- 4759US2010129320A1Quinoline derivatives for modulating dna methylationSUPERGEN INC·Filed 2009·Application pending·0 cites
- 4859US2004014695A1Pharmaceutical formulationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 4955US7049322B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted May 23, 2006·0 cites·12 claims
- 5054US2006063735A1Salts of 5-azacytidineSUPERGEN INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →